Press Releases for 2023
ZOLL Expands Temperature Management Portfolio to Include IQool™ System, High-Quality Surface Option
Monday, July 24, 2023 in Chelmsford, Mass.
ZOLL remedē System, a Breakthrough Therapy for Treating Central Sleep Apnea, Receives Approval for MRI Conditional UseWednesday, May 24, 2023 in Chelmsford, Mass.
Results from Benefit of Microcor in Acute Decompensated Heart Failure (BMAD) Trial Presented as ACC.23/WCC Late-Breaking Clinical TrialMonday, March 6, 2023 in Chelmsford, Mass.
First Patient Enrolled in REAL SSO2 Study to Evaluate Clinical Utility and Economic Value of ZOLL TherOx SSO2 TherapyTuesday, January 17, 2023 in Chelmsford, Mass.